Accessibility
EasyRead Text Version
Showing 1 to 2 of 2 Results
Taliou A. et al. (2013)
An open-label pilot study of a formulation containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children with autism spectrum disorders.
Clinical Therapeutics
35(5), pp. 592-560.
Read Abstract (New Window)
Tsilioni I. et al. (2015)
Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6.
Translational Psychiatry
5 e647.
Read Abstract (New Window) Read Full (New Window)
Publications | Publications Database | Search Publications
Rate This Page
Poor | Satisfactory | Good | Excellent
Print This Page / view All
Back to top
Your Rating: